News From RSC-NJ
RSC-New Jersey Welcomes new doctor!
"I am delighted to join the team of physicians, nurses, and support staff at RSCNJ. It is an honor and a privilege to work alongside such wonderful professionals committed to outstanding and compassionate patient care."- DR. JESSICA SALAS MANN
Read full announcement and DR. Jessica Salas Mann's bio...Dr. William Ziegler answers your infertility questions in Ask the Experts
For many in our audience who are not familiar with the science of Reproductive Endocrinology and Infertility maybe you can provide a brief overview?
Reproductive Endocrinology and Infertility is a branch of medicine that identifies and treats infertility in both men and women. In the United States, 15 percent of all couples will face fertility issues, and many will be diagnosed with a reproductive disorder. Many infertile couples choose to see a reproductive endo- crinologist when deciding upon fertility treatments. The reproductive endocrinologist will identify factors involved in a couple’s infertility and select the appropriate methods to treat these factors.
Read more of Dr. William Ziegler's "Ask the Experts" article...
Check out our new blog! Preservation and Postponement of Fertility – A Field Emerging From Infancy
The science of Reproductive Medicine has seen amazing advances in the last several years. But some of the most exciting advances have come in the area of preservation of female fertility. Fertility preservation is of utmost importance to women of reproductive age who have developed a cancer or disease that threatens their ability to have children in the future. And these new advances can't come at a more important time. It has been estimated 1 in 250 adults will be a cancer survivor. In recent surveys, 75% of patients with cancer have stated that they want children in the future, 80% feel that their cancer experience would make them better parents, 67% would want a child even if they were to die young.
Read more>>
New Advances in the art of creating a baby
Nearly one in six couples in the U.S. struggles with some degree of infertility. In these cases, it is crucial to consult with a physician who is on the cutting edge of this fast-paced field. At the Reproductive Science Center of New Jersey, we offer a wide range of fertility services, from evaluation, to the most advanced reproductive procedures including egg donation. But what really sets us apart is our experience and expertise in newer, cutting edge procedures.
In the area of fertility, we are able to evaluate the genetic makeup of embryos through a procedure called PGD (pre-implementation genetic diagnosis), which is used to test the genetic makeup of an embryo for possible disorders before placing it in the uterus. The Reproductive Science Center of New Jersey center recently had the first pregnancy in Monmouth and Ocean counties utilizing CGH (comparative genomic hybridization), the latest advance in PGD.
Another area in which great strides have been made in the field of Reproductive Medicine is in fertility preservation. For women with cancer or other diseases in which treatment may harm their future fertility, there are now more options than ever for protecting their eggs and ovaries. We are now able to cryopreserve, or freeze, eggs and embryos, and some women are even opting to preserve ovarian tissue that contains eggs for possible future transplantation as well.
Robotic surgery is also now being used to treat a number of gynecological problems and has greatly improved the outcome and shortened the recovery time. All of the surgeons at the Reproductive Science Center of New Jersey are trained in robotic surgery, and Dr. Ziegler and Dr. Bromer recently performed the first robotic assisted tubal reversal surgeries in Monmouth and Ocean Counties.
Jason G. Bromer M.D.,F.A.C.O.G. Reproductive Science Center of New Jersey
Study of chemical found in plastics and fetal developement
Bisphenol A (BPA), a chemical compound commonly found in plastics, may have long-term effects on fetal development, according to an article published by Yale School of Medicine researchers last month in the Journal of the Federation of American Societies for Experimental Biology. The results of the study come weeks after the Food and Drug Administration announced that exposure to BPA was of "some concern" to infants and children.
Bromer, who was a fellow at Yale during the study, said researchers now need to determine the levels of BPA exposure that are significant enough to impact fetal development.
Click here to read full article about BPA study.
New Doctor Joins RSC-New Jersey-November, 2009
Dr. Bromer is a specialist in Reproductive Endocrinology and Infertility, and the newest associate of the Reproductive Science Center of New Jersey. He holds teaching positions at both training institutions in Monmouth County; Monmouth Medical Center and Jersey Shore University Medical Center (an Affiliate of the Robert Wood Johnson Medical Center), and he enjoys working with medical students and residents training in Obstetrics and Gynecology.
Dr. Bromer also works closely with Dr. Ziegler in conjunction with these teaching centers to organize continuing medical education programs available to all medical professionals in the community. He is a member of the New Jersey Medical Society, the American Society of Reproductive Medicine, the Society for Reproductive Endocrinology and Infertility, and the International Society for Fertility Preservation. He is a fellow of the American College of Obstetricians and Gynecologists, and is a Diplomat of the American Board of Obstetrics and Gynecology.
Dr. Bromer’s aim is to provide current, high quality medical treatment to his patients in a sensitive, caring, and compassionate environment.
Click here to read full bio.